Objective: To compare changes in apolipoprotein B (apoB), low-density lipoprotein cholesterol (LDL-C), and additional lipid biomarkers by treatment with lipid lowering medications (LLM) when following ...

She turned over and continued to sleep with her back to him.Hu Ningao couldn t Blood Sugar Reading Of 1200 - The Glycemic Response To Lipid-Lowering Medications bear to wake her is 100 a good blood ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

One in four patients who present with elevated low-density lipoprotein cholesterol levels have no documented use of statin therapy, according to a study published April 16 in Epic Research.  Here are ...

This study seeks to use Mendelian randomisation (MR) to assess the causal relationship between lipid traits and lipid-lowering drug targets and full-course DR (background DR, severe non-proliferative ...

Researchers saw a greater reduction in LDL-C, as well as all-cause mortality, major adverse CV events, and stroke incidence in patients using combination lipid-lowering therapy. HealthDay News — ...

A greater reduction LDL-C was seen for combo therapy; reductions also seen in all-cause mortality, major adverse CV events, stroke incidence. HealthDay News — Combination lipid-lowering therapy ...

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...